Tracks

Scientific Tracks at OncoAITransMed 2027

Browse dedicated focus areas spanning oncology AI, translational medicine, digital pathology, and clinical intelligence.

Artificial Intelligence in Oncology: Emerging Trends and Future Perspectives

Description: Explores the latest AI innovations transforming cancer research, diagnosis, and treatment. Highlights future opportunities for intelligent oncology solutions. Who Should Attend: Oncologists, AI researchers, healthcare professionals, data scientists, and cancer researchers.

AI-Based Cancer Diagnosis and Clinical Decision Support

Description: Focuses on AI-powered diagnostic systems, predictive tools, and decision-support technologies improving clinical accuracy and efficiency. Who Should Attend: Clinicians, oncologists, radiologists, medical researchers, and healthcare AI developers.

Precision Oncology and AI-Driven Personalized Medicine

Description: Explores AI approaches for personalized cancer treatment using genomic, clinical, and patient-specific data. Who Should Attend: Oncologists, precision medicine specialists, genomic researchers, and biomedical data scientists.

Machine Learning in Cancer Research and Drug Discovery

Description: Highlights machine learning applications in identifying therapeutic targets, predicting drug responses, and accelerating cancer drug development. Who Should Attend: Pharmaceutical researchers, computational scientists, AI specialists, and oncology researchers.

AI in Medical Imaging and Radiology for Cancer Care

Description: Covers AI applications in medical imaging, tumour detection, image analysis, and automated diagnostic workflows. Who Should Attend: Radiologists, imaging scientists, oncologists, biomedical engineers, and AI developers.

Cancer Genomics, Bioinformatics, and AI-Based Molecular Analysis

Description: Explores AI-driven analysis of genomic data, molecular profiling, and biological insights for cancer research. Who Should Attend: Geneticists, bioinformaticians, molecular biologists, and computational oncology researchers.

AI-Powered Biomarkers and Early Cancer Detection

Description: Focuses on intelligent approaches for discovering biomarkers, liquid biopsy analysis, and early cancer diagnosis. Who Should Attend: Molecular researchers, diagnostic specialists, clinicians, and biotechnology professionals.

Immuno-Oncology and AI-Based Immune Response Prediction

Description: Examines AI applications in immunotherapy research, immune profiling, and predicting treatment responses. Who Should Attend: Immunologists, oncologists, translational researchers, and AI scientists.

Digital Health, Wearable Technologies, and Remote Cancer Monitoring

Description: Explores digital healthcare solutions, wearable devices, and AI-based monitoring systems for cancer management. Who Should Attend: Digital health experts, clinicians, engineers, healthcare innovators, and data scientists.

AI in Radiation Oncology and Treatment Optimization

Description: Highlights AI-driven radiation planning, precision therapy, and optimization of cancer treatment strategies. Who Should Attend: Radiation oncologists, medical physicists, AI researchers, and oncology professionals.

AI-Assisted Surgical Oncology and Robotic Cancer Surgery

Description: Covers artificial intelligence, robotics, and advanced technologies improving surgical precision and outcomes. Who Should Attend: Surgical oncologists, robotic surgeons, biomedical engineers, and healthcare technology experts.

Translational Research and AI-Enabled Clinical Trials

Description: Explores AI applications in clinical trial design, patient selection, data analysis, and therapy development. Who Should Attend: Clinical researchers, pharmaceutical professionals, trial coordinators, and medical data analysts.

Generative AI and Large Language Models in Healthcare and Oncology

Description: Discusses applications of generative AI, language models, and intelligent assistants in cancer research and healthcare delivery. Who Should Attend: AI scientists, healthcare informatics experts, clinicians, and technology innovators.

Ethical AI, Data Privacy, and Responsible Innovation in Medicine

Description: Addresses challenges in AI governance, healthcare data security, transparency, and responsible clinical implementation. Who Should Attend: Healthcare leaders, policymakers, AI ethicists, researchers, and data security professionals.

Future Frontiers in AI-Driven Oncology and Precision Healthcare

Description: Explores emerging technologies shaping the future of AI-powered cancer prevention, diagnosis, and treatment. Who Should Attend: Oncologists, researchers, AI innovators, healthcare executives, academicians, and students.